3D Microcavity Sensor Films for Cardiomyocyte Oxygen Gradients
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring oxygen concentrations and gradients in 3D cell cultures, particularly for cardiomyocytes or cardiac organoids, are inadequate, leading to unphysiological conditions and limited ability to assess cardiotoxicity and ischemic toxicity effectively.
Innovation Solution
The method involves using three-dimensional structures formed from fluorophore-doped oxygen-sensitive sensor films to measure oxygen concentrations and gradients in 3D cell cultures, allowing for simultaneous observation of other physiologically relevant parameters like intracellular calcium concentrations, CO2, glucose, and pH.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If planar film systems are used for oxygen measurement, then the measurement is sufficient for two-dimensional cell cultivation, but it cannot determine oxygen concentrations and gradients in the immediate microenvironment of 3D cell cultures
Solution Approach 1:
The patent transitions from two-dimensional planar film systems to three-dimensional microcavity structures. The microcavities provide a volumetric measurement space that matches the 3D architecture of cell cultures, enabling oxygen concentration and gradient determination throughout the entire microenvironment rather than only at a single planar interface.
Solution Approach 2:
The patent embeds multiple measurement functionalities within nested structures. The microcavities contain sensor elements that measure oxygen, while also enabling simultaneous measurement of other parameters like pH, glucose, and calcium through integrated sensor systems within the same 3D structure.
2Ease of operation
If ambient atmosphere (21% oxygen) is used for cell culture, then cell cultures can be cultivated easily, but it creates oxygen overload (hyperoxia) and stressful conditions with unphysiological responses
Solution Approach 1:
The patent implements continuous oxygen concentration monitoring in the cell culture microenvironment using the 3D microcavity sensor system. This feedback enables dynamic adjustment of oxygen levels to maintain physiological conditions, allowing cells to respond naturally to their microenvironment rather than to artificial hyperoxia.
Solution Approach 2:
The patent enables precise control and adjustment of oxygen concentration parameters in the cell culture system. By measuring and regulating oxygen levels to match physiological ranges (0.5-14% depending on tissue type), the system transforms from static ambient atmosphere cultivation to dynamic physiological condition maintenance.
3Measurement precision
If oxygen-consuming electrodes are used for oxygen measurement, then oxygen concentrations can be measured, but the measurement accuracy is compromised due to oxygen consumption by the electrodes
Solution Approach 1:
The patent replaces electrochemical oxygen-consuming electrodes with optical fluorophore-based sensing systems. The fluorophores emit light signals that are modulated by oxygen concentration through dynamic fluorescence quenching, enabling oxygen measurement without consumption or interference with the cellular microenvironment.
4Loss of information
If multiple parameters (oxygen, calcium, CO2, glucose, pH) are measured simultaneously, then more comprehensive physiological data is obtained, but the system complexity increases
Solution Approach 1:
The patent creates a universal 3D microcavity measurement platform that can simultaneously detect multiple physiological parameters (oxygen, pH, glucose, calcium, CO2) through integrated sensor systems. This multi-functional approach consolidates what would otherwise require separate measurement systems into a single unified platform, reducing overall system complexity while maximizing information completeness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables more physiologically relevant in vitro models for investigating cardiotoxicity and ischemic toxicity, improving the transferability of in vitro results to the in vivo situation and providing more accurate data on the effects of substances on mitochondrial respiration and cardiac function.
Implementation Method 1
Oxygen can be determined using dynamic fluorescence quenching. This involves exciting a fluorophore by irradiating it with light of a specific wavelength, which then either emits the fluorescence emission light or transfers it non-radiatively to an oxygen molecule.
Data Source
Figure 1(A)~2(F)
Figure 3(A)~3(E)
Figure 4(A)~5(D)
AI summary
The invention relates to a method for the in vitro measurement of oxygen concentrations and/or oxygen concentration gradients in 3D cell cultures of cardiomyocytes or in cardiac organoids (HFOs) in three-dimensional structures formed from fluorophore-doped oxygen-sensitive sensor films, optionally in combination with the measurement of other physiologically relevant parameters. This thus provides new, more physiologically relevant in vitro models for the investigation of cardiotoxicity and ischemic toxicity.